EDSA (Edesa Biotech Inc) Net Profit

EDSA (Edesa Biotech) - company brandmark

Stable management focused on completing late-stage trials of anti-inflammatory agents creates a positive backdrop for Edesa Biotech, Inc. (EDSA). The company's commercial results confirm this trend, where the value of -0.01 expresses the metric level. Growth is driven by the success of the EB05 drug and the orphan status of its developments, while operational efficiency is maintained through specialized cold-chain logistics and the diversification of research centers.

EDSA (Edesa Biotech, Inc.) Net Profit history from 07/04/2022 to 10/30/2026
Core merchandise of Edesa

Efficient cold chain logistics and hub diversification at Edesa Biotech, Inc. (EDSA) ensure high operational profitability, directly impacting the bottom line. An analysis of the company's profit levels allows for an assessment of the net cash balance after all expenses, where the absence of sharp drawdowns on the chart confirms the lack of cash flow gaps and the fundamental stability of the business.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Company Net Income Pharming Corp|NKTR: Net Profit|Company Profit UPB|ZBIO (Zenas Biopharma) - Net Profit|Company Net Income Immunome Inc IMNM|Company Net Income Gossamer Corp (GOSS)|Net Financial Result KalVista Corp|Net Profit SEPN (Septerna Inc)|Net Profit pieris.com PVLA|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB: Net Profit|ATXS (Astria Corp) - Company Net Income|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS - Company Net Income|Kyverna - Net Income|Profit After Payment of Taxes TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Net Profit|Company Net Income ventyxbio.com|THTX: Net Profit|Net Income Avalo Therapeutics, Inc.|ELDN (Eledon) - Net Profit|AGEN: Final Profit|Net Income CLYM (Climb Bio Inc)|ZURA (zurabio.com) - Final Profit|Net Profit ATYR (aTyr Pharma)|Net Financial Result Adagene Inc (ADAG)|IMA - Company Net Income|STTK (Shattuck Labs, Inc.) - Company Profit|EQ: Net Profit|Net Income Connect Biopharma Holdings Limited|Net Income IMUX|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Net Profit IFRX|XFOR - Company Net Income|Net Profit ACET (Adicet Bio, Inc.)|CELU: Company Profit|INMB - Company Net Income|Net Financial Result Barinthus Biotherapeutics PLC BRNS|KZR: Net Profit|SAB Biotherapeutics Inc (SABS) - Net Profit|Company Net Income Akari Therapeutics|Enlivex Therapeutics, Ltd. - Profit After Tax|Net Profit QTTB|GOVX (GeoVax Labs) - Final Profit|Net Profit IBIO (iBio Corp)|Net Profit Carisma Therapeutics Inc CARM|XTLB - Company Net Income|Final Profit BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Company Net Income|Net Income Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Net Profit|Net Profit Aditxt Corp|Net Income GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Final Profit|Net Profit HIND (Vyome Holdings)|Net Financial Result Revelation Biosciences Inc (REVB)|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|Net Income ALLK|Net Profit HOOKIPA|Company Net Income IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Company Profit|Net Profit OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Company Net Income|Third Harmonic Bio, Inc. - Net Profit